Chemical restraint in aged care – we can reduce use

Fred was a resident with Alzheimer’s disease living at one of our aged care homes. He was a quiet man; in fact, Fred had not spoken for years. Like many people with dementia he became agitated and upset, particularly around evening meals. He would refuse to eat at certain times. Two years ago Fred was prescribed a small dose of risperidone, an antipsychotic, to help him settle.

Please login below to view content or subscribe now.

Membership Login